AthenaDAO
AthenaDAO (AthenaBIO) is a decentralized biotech DAO founded in 2022 that funds and incubates translational women's health research via Ethereum-based IP-NFTs and the ATH governance token, serving academic researchers, women consumers, and accredited investors.
- Company typePrivate
- Founded2022
- HeadquartersSan Francisco, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What AthenaDAO does
AthenaDAO (now operating as AthenaBIO) is a decentralized autonomous organization founded in 2022 in San Francisco that sources, funds, and incubates translational women's health research. The organization addresses the structural underfunding of women's health, where approximately 1% of healthcare R&D is invested in female-specific conditions beyond oncology, by operating a BioDAO model that combines Ethereum-based infrastructure with community governance. Its core technical architecture leverages Molecule's IP-NFT framework to issue and trade research intellectual property as non-fungible tokens on the Ethereum blockchain, with the ATH governance token enabling community voting on research proposals and funding allocations. Active funded programs include F/ACC (cGAS-STING pathway and ovarian aging research led by Dr. Mario Cordero), OVARIA (AI-driven target discovery with Gero AI using GWAS data from Estonian and UK Biobanks), IP-NFT 2 (Integrated Stress Response research with Dr. Joshua Johnson targeting Primary Ovarian Insufficiency), and the LifeAhead spin-out (personalized ovarian aging forecasting tool derived from CU Anschutz, University of Utah, and Yale research).
AthenaDAO's product portfolio extends beyond research funding into commercial and educational offerings. LifeAhead, a spun-out entity, is an AI-assisted tool that predicts individual reproductive milestones using biological markers with approximately 75% less uncertainty than population-level estimates. The Fertility 101 Course is a 6-week online educational product priced at $250 full price or $150 for early-bird, special-pricing, and ATH token holders, with 25 scholarships available for university students and postdocs. The organization also publishes three volumes of its Reproductive Health Report covering ovarian aging, PCOS and endometriosis, and gynecological cancers, and hosts the annual AthenaBIO Summit (inaugural 2024 in Cascais, Portugal) and the AB Labs Pop-Up Shop (San Francisco, October 2024).
The business model is a hybrid of nonprofit grant-making and nascent commercial revenue. Capital inflows include tax-deductible donations via Stripe (suggested $5-$50 for ATH governance tokens, with gift agreements for contributions of $10K or more routed through the AthenaBIO Foundation), governance token sales, course fees, and an equity investment vehicle being developed for accredited investors. Capital outflows are grants of $50-150K per project over 1-2 year R&D periods, plus support for legal, strategic, and scientific mentorship. The customer base spans academic researchers (primary), women consumers (educational), women's health startups (dealflow), and investors/philanthropists (capital providers). The legal entity is AthenaBIO, operating under the AthenaDAO brand for historical continuity, and the organization is governed through working groups (Operations, Science & Dealflow, Comms & Awareness, Tokenomics & Governance) rather than traditional corporate management.
AthenaDAO firmographics
Firmographics- Name
- AthenaDAO
- Legal name
- AthenaBIO
- Website
- https://athenadao.co
- Company type
- Private
- Founded year
- 2022
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- AthenaDAO (AthenaBIO) is a decentralized biotech DAO founded in 2022 that funds and incubates translational women's health research via Ethereum-based IP-NFTs and the ATH governance token, serving academic researchers, women consumers, and accredited investors.
- Ownership category
- akta.pro rank
AthenaDAO industry classification
Industry- Product category
- Decentralized Science Funding
- NAICS
- Voluntary Health Organizations (813212)
- SIC
- Finance Services (6199)
- akta.pro primary industry
- DAO Treasury, Governance & On-Chain Finance Tools (FSADAMAL)
- akta.pro secondary industries
- Grants, Funding & Budget Allocation Platforms (FSAPAHAE), Governance Frameworks & DAO Tooling (modules, templates, standards) (FSAPAHAC), Coordination & Contributor Management (tasks, bounties, roles) (FSAPAHAD)
Keywords
Where AthenaDAO is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Markets served
AthenaDAO business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Others, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Governance Token (ATH): ATH tokens provide governance rights and allow supporters to participate in funding decisions. Token holders can vote on research proposals and funding allocations, creating a community-driven funding mechanism.
- Educational Courses: 6-week online Fertility 101 Course offered at $250 full price, $150 early bird/special pricing, with scholarships available. Course covers reproductive health topics and provides certificate of completion.
- Donations and Philanthropy: Tax-deductible donations via Stripe supporting the research grant fund. Suggested amounts of $5, $10, $25, $50 for governance tokens, with larger philanthropic gifts accepted for the AthenaBIO Foundation.
- Equity Investment: Investment vehicle being developed for accredited investors seeking exposure to women's health biotechnology and intellectual property.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Full Course Price - Standard enrollment |
| One time/ perpetual license | Pay-as-you-go | Early Bird Price |
| One time/ perpetual license | Pay-as-you-go | Special Pricing - AB Labs Pop Up Attendees |
| One time/ perpetual license | Pay-as-you-go | ATH Token Holders |
| Freemium | Pay-as-you-go | Scholarship Program |
| Subscription | Monthly | Governance Token Donation |
| Other | Multi-year contract | Philanthropic Foundation Gift |
Go-to-market motion1 record
Distribution channels7 records
Marketing channels12 records
AthenaDAO product offering
Product offeringCore offering
AthenaDAO (also known as AthenaBIO) is a decentralized autonomous organization (BioDAO) that sources, funds, and incubates translational women's health research through blockchain-based mechanisms. It provides researchers with funding ($50–150K per project over 1–2 years), legal and strategic mentorship, and IP licensing via IP-NFTs issued on Ethereum. It operates an ATH governance token for community voting on research priorities, and offers paid educational courses, reproductive health reports, and a global community platform connecting researchers, funders, and advocates.
Product overview
AthenaDAO is a decentralized biotech DAO (BioDAO) that sources, funds, and incubates translational women's health research. The organization operates as a platform combining blockchain-based IP-NFT funding mechanisms with community-driven governance via the ATH token. Key offerings include LifeAhead (AI-powered ovarian aging prediction tool), the Fertility 101 Course (educational platform), Reproductive Health Reports (research publications), the AthenaDAO Summit (annual conference), and IP-NFT funded research projects targeting ovarian aging, menopause, gynecologic cancers, PCOS, endometriosis, and fertility. The community platform connects researchers with funders through working groups focused on science, communications, operations, and governance.
Differentiator
Problem solved
Functional benefit
Brands
- LifeAhead: A personalized ovarian aging forecasting tool built on research from CU Anschutz, University of Utah, and Yale. Predicts individual reproductive milestones with roughly 75% less uncertainty than population-level estimates.
- ReproTech
- Fertility 101 Course
Products and services
- LifeAhead A personalized ovarian aging forecasting tool that predicts individual reproductive milestones (e.g., menopause and perimenopause timing) using biological markers collected at routine fertility clinic consultations, with approximately 75% less uncertainty than population-level estimates. Built for women and clinicians seeking personalized reproductive health forecasting.
- Fertility 101 Course A 6-week online educational course covering reproductive health topics including egg freezing, IVF, perimenopause, and menopause, with two specialized tracks (Fertility Preservation and Post-Fertility). Delivered to women and learners seeking evidence-based fertility education, including live sessions, recordings, course materials, community forum access, and a certificate of completion.
- IP-NFT Research Funding Mechanism Blockchain-based intellectual property non-fungible tokens issued on Ethereum that enable funding and trading of women's health research IP rights, using Molecule's IP-NFT Framework to provide secure IP ownership and exclusive licensing mechanisms. Used by researchers and startups in women's health to access alternative capital and IP licensing.
- ATH Governance Token Native governance token that allows supporters to participate in funding decisions and vote on research proposals and funding allocations for women's health projects. Available to community members and crypto contributors seeking direct influence over research priorities.
Quantifiable outcome
- ~$14 billion economic impact estimated from $350 million investment in women's health research (McKinsey)
- +1 more outcomes
Companies that use AthenaDAO
Customer profileNamed customers8 records
Segments4 records
Ideal customer profiles4 records
AthenaDAO technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature3 records
AthenaDAO partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and minor.
- Merito NetworkcoreStrategic collaboration announced January 9, 2025 to advance reproductive longevity and fertility research specifically focused on the Japanese market. Combines AthenaBIO's funding mechanisms with Merito Network's regional expertise to expand women's health research reach.
- Gero AIcorePartnership with Series A biotech company Gero AI for AI-driven target discovery in ovarian aging. Uses Gero's machine learning platform to analyze GWAS data from Estonian and UK Biobanks, aiming to identify up to 10 novel therapeutic targets for ovarian aging. Drug development would occur collaboratively.
- MoleculecoreUses Molecule's IP-NFT Framework to issue and trade research IP rights on Ethereum blockchain. This technical infrastructure enables AthenaDAO's novel funding model by providing secure IP ownership and exclusive licensing mechanisms recorded on-chain.
- NOVA SBE (NOVA School of Business & Economics)minorExclusive venue partner for inaugural AthenaBIO Summit 2024 held March 19-21 in Cascais, Portugal. Provided access to one of the top Business Schools in the world for the event.
- RippleminorEvent partner for the AthenaBIO Summit 2024. Supported the inaugural women's health R&D Summit event bringing together researchers, funders, and contributors.
- NOVA Data Science Knowledge CenterminorData Science Knowledge Center partner for AthenaBIO Summit 2024, supporting the event held at NOVA SBE in Cascais, Portugal.
- OneSkinminorWomen's health biotech brand featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.
- GlycanAgeminorWomen's health brand featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.
- OvulminorWomen's health startup (hormonal tracking device) featured as community partner at AB Labs Pop-Up San Francisco, October 2024. Conducted breakfast event during the pop-up experience.
- FertiscoreminorWomen's health brand listed as community partner for AB Labs Pop-Up San Francisco, October 2024.
- SheFiminorWellness activation partner for AB Labs Pop-Up San Francisco, October 2024. Organization supporting women in fintech and crypto.
- RootlessminorWellness activation partner for AB Labs Pop-Up San Francisco, October 2024.
- Ultra Violet AgencyminorWellness activation partner for AB Labs Pop-Up San Francisco, October 2024. Managing Director Anna Butterworth featured as speaker.
Scale indicators7 records
Recent moves7 records
Expansion highlights6 records
AthenaDAO competitors and assessment
Company assessmentDirect peers
- VitaDAO: VitaDAO is a BioDAO funding longevity research via IP-NFTs and community governance on Ethereum. It is the closest direct peer to AthenaDAO, sharing the DeSci funding model, Molecule integration, and ATH-style governance token — but focused on aging rather than women's health.
- HairDAO: HairDAO is a DeSci DAO funding hair loss research through community governance and IP-NFTs on Molecule. It directly parallels AthenaDAO's structure and funding mechanism but targets dermatology rather than reproductive health.
- CryoDAO: CryoDAO is a BioDAO funding cryopreservation and organ preservation research via community governance and IP-NFTs. It shares the DeSci funding model and translational research focus with AthenaDAO but operates in an adjacent biotech vertical.
- ValleyDAO: ValleyDAO is a BioDAO funding synthetic biology and engineering biology research through IP-NFTs and token-based governance. It shares the DeSci funding infrastructure and academic-to-spin-out incubation thesis with AthenaDAO.
- Bio.xyz: Bio.xyz is a launchpad and accelerator for BioDAOs, providing tooling, legal, and operational infrastructure for new DeSci DAOs including AthenaDAO-adjacent models. It is comparable as both a peer and ecosystem enabler for community-led biotech funding.
- CerebrumDAO: CerebrumDAO is a DeSci DAO funding brain health and neuroscience research through community governance and IP-NFTs. It shares AthenaDAO's structure, IP-NFT funding model, and focus on a chronically underfunded therapeutic area.
- HydraDAO: HydraDAO is a BioDAO funding aging and regeneration research using Hydra and comparative biology models through IP-NFTs. It directly parallels AthenaDAO's DeSci funding structure and longevity-adjacent scientific focus.
Others
- Molecule: Molecule is the IP-NFT infrastructure provider that AthenaDAO depends on for research IP tokenization. As a technology and protocol partner, Molecule enables the funding mechanism but also serves other BioDAOs, making it an adjacent ecosystem player rather than a direct competitor.
Emerging players
- ResearchHub: ResearchHub is a decentralized scientific publishing and peer-review platform with token incentives for contributors. It overlaps with AthenaDAO's community-funded science model but focuses on publishing and discussion rather than IP-NFT research funding.
- Pump Science: Pump Science is a DeSci launchpad for longevity and supplement research using tokenized funding on Solana. It shares the community-driven biotech funding thesis with AthenaDAO but uses a different chain and product format.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks1 record
Key highlights7 records
Customer concentration
AthenaDAO social profiles
Digital presenceAthenaDAO financial estimates
Financial estimateRevenue estimate
Valuation estimate
AthenaDAO leadership team
Management profileNumber of profiles
Profiles9 records
AthenaDAO funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
AthenaDAO M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about AthenaDAO
What does AthenaDAO do?
AthenaDAO (also known as AthenaBIO) is a decentralized autonomous organization (BioDAO) that sources, funds, and incubates translational women's health research through blockchain-based mechanisms. It provides researchers with funding ($50–150K per project over 1–2 years), legal and strategic mentorship, and IP licensing via IP-NFTs issued on Ethereum. It operates an ATH governance token for community voting on research priorities, and offers paid educational courses, reproductive health reports, and a global community platform connecting researchers, funders, and advocates.
Is AthenaDAO a public or private company?
AthenaDAO is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was AthenaDAO founded?
AthenaDAO was founded in 2022. It employs 11 to 50 people.
Where is AthenaDAO based?
AthenaDAO is headquartered in San Francisco, United States, in the North America region.
How does AthenaDAO make money?
Four revenue lines are on record. Governance Token (ATH) is the primary driver. The others are educational Courses, donations and Philanthropy and equity Investment.
Who are AthenaDAO's main competitors?
Direct peers on record are VitaDAO, HairDAO, CryoDAO, ValleyDAO, Bio.xyz, CerebrumDAO and HydraDAO. Molecule is listed as an others. Emerging players are ResearchHub and Pump Science.
Does AthenaDAO have an API?
No public API is recorded for AthenaDAO.
What industry is AthenaDAO in?
AthenaDAO's product category is Decentralized Science Funding. Its primary akta.pro industry code is FSADAMAL, DAO Treasury, Governance & On-Chain Finance Tools, with a secondary code of FSAPAHAE, Grants, Funding & Budget Allocation Platforms. Its NAICS code is 813212 and its SIC code is 6199.